Emilien, G.
374  Ergebnisse:
Personensuche X
?
2

P.3.058 Venlafaxine XR and paroxetine in the short-term tre..:

Lepola, U. ; Pollack, M. ; Emilien, G...
European Neuropsychopharmacology.  13 (2003)  - p. S378 , 2003
 
?
3

P.3.057 Treatment of panick disorder with venlafaxine XR:

Ahokas, A. ; Bradwejn, J. ; Emilien, G..
European Neuropsychopharmacology.  13 (2003)  - p. S377-S378 , 2003
 
?
4

Haemophilias: advances towards genetic engineering replacem..:

Emilien, G. ; Maloteaux, J.-M. ; Penasse, C...
Clinical & Laboratory Haematology.  22 (2000)  6 - p. 313-323 , 2000
 
?
6

The dose-response relationship in Phase I clinical trials a..:

Emilien, G
Pharmacology & Therapeutics.  88 (2000)  1 - p. 33-58 , 2000
 
?
7

Dopamine receptors—physiological understanding to therapeut..:

Emilien, G
Pharmacology & Therapeutics.  84 (1999)  2 - p. 133-156 , 1999
 
?
8

Current therapeutic uses and potential of β-adrenoceptor ag..:

Emilien, G. ; Maloteaux, J.-M. ; Emilion, G.
European Journal of Clinical Pharmacology.  53 (1998)  6 - p. 389-404 , 1998
 
?
9

Zaleplon decreases sleep latency in outpatients after 4 wee..:

Emilien, G. ; Salinas, E.
European Neuropsychopharmacology.  8 (1998)  - p. S297 , 1998
 
?
15

Prospects for quarkonium studies at the high-luminosity LHC:

Chapon, Émilien ; d'Enterria, David ; Ducloué, Bertrand...
Progress in Particle and Nuclear Physics.  122 (2022)  - p. 103906 , 2022
 
1-15